Sorry, there are currently no headlines for this topic.
About our Sputnik V news
Latest news on Sputnik V, a Russian-developed Covid 19 vaccine. Sputnik V is a viral vector vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is composed of two adenoviruses, Ad26 and Ad5, modified to carry the gene for the spike protein of SARS-CoV-2, the virus that causes COVID-19. The vaccine has been shown to be highly effective in clinical trials, with an overall efficacy rate of over 90%, and has been approved for emergency use in dozens of countries around the world. Sputnik V has also been at the centre of controversy, with some Western countries raising concerns over its safety and efficacy, and Russia accusing Western powers of attempting to undermine the vaccine.